Babesia gibsoni: Detection during experimental infections and after combined atovaquone and azithromycin therapy

Experimental Parasitology

Volumn 117, Issue 2, 2007, Pages 115-123

  Jefferies, R ^a   Ryan, U M ^a   Jardine, J ^b   Robertson, I D ^a   Irwin, P J ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b Vetpath Laboratory Services   (Australia)

Author keywords

Atovaquone; Azithromycin; Babesia gibsoni; Canine; Dog; EDTA; ethylenediamine tetra acetic acid; FITC; Flinders Technology Associates; fluorescein isothiocyanate; FTA; haematocrit; haemoglobin concentration; HCT; HGB; IFAT; immunofluorescent antibody test; intravenously; IV; MCV; mean corpuscular volume; mean platelet volume; MPV; PBS; PCR; phosphate buffered saline; platelet number; PLT; polymerase chain reaction; RBC; red blood cell count; WBC; white blood cell count

Indexed keywords

ATOVAQUONE; AZITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABESIA; BABESIA GIBSONI; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL INFECTION; FEMALE; HEMATOLOGY; IMMUNOFLUORESCENCE TEST; IN VIVO CULTURE; INTERMETHOD COMPARISON; MICROSCOPY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTOZOAL INFECTION;

ACUTE DISEASE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBODIES, PROTOZOAN; ATOVAQUONE; AZITHROMYCIN; BABESIA; BABESIOSIS; CHRONIC DISEASE; DNA, PROTOZOAN; DOG DISEASES; DOGS; DRUG RESISTANCE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; PARASITEMIA; POLYMERASE CHAIN REACTION;

BABESIA GIBSONI; CANIS FAMILIARIS; MOROCCAN PEPPER VIRUS; PROTOZOA; TETRA;

EID: 34548263601     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2007.03.016     Document Type: Article

References (45)

1. Allred D.R., and Al-Khedery B. Antigenic variation and cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal. Molecular and Biochemical Parasitology 134 (2004) 27-35
2. Anderson J.F., Magnarelli L.A., and Sulzer A.J. Canine babesiosis: indirect fluorescent antibody test for a North American isolate of Babesia gibsoni. American Journal of Veterinary Research 41 (1980) 2102-2105
3. Ano H., Makimura S., and Harasawa R. Detection of Babesia species from infected dog blood by polymerase chain reaction. Journal of Veterinary Medical Science 63 (2001) 111-113
4. Beban H. Absence of Babesia gibsoni in New Zealand dogs. Surveillance 30 (2003) 9-11
5. Birkenheuer A., and Marr H. Babesia gibsoni cytochrome b gene analysis. ACVIM abstracts. The Journal of Veterinary Internal Medicine 19 (2005) 386-398
6. Birkenheuer A.J., Levy M.G., and Breitschwerdt E.B. Development and evaluation of a seminested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and B. canis DNA in canine blood samples. Journal of Clinical Microbiology 41 (2003) 4172-4177
7. Birkenheuer A.J., Levy M.G., Stebbins M., Poore M., and Breitschwerdt E. Serosurvey of antibabesia antibodies in stray dogs and American Pit Bull Terriers and American Staffordshire Terriers from North Carolina. Journal of the American Animal Hospital Association 39 (2003) 551-557
8. Birkenheuer A.J., Levy M.G., and Breitschwerdt E.B. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. The Journal of Veterinary Internal Medicine 18 (2004) 494-498
9. Birkenheuer A.J., Correa M.T., Levy M.G., and Breitschwerdt E.B. Geographic distribution of babesiosis among dogs in the United States and association with dog bites: 150 cases (2000-2003). Journal of the American Veterinary Medical Association 227 (2005) 942-947
10. Bonoan J.T., Johnson D.H., and Cunha B.A. Life threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone. Heart and Lung 27 (1998) 424-428
11. Brandao L.P., Hagiwara M.K., and Myiashiro S.I. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate. Veterinary Parasitology 114 (2003) 253-265
12. Braga E.M., Fontes C.J., and Krettli A.U. Persistence of humoral response against sporozoite and blood-stage malaria antigens 7 years after a brief exposure to Plasmodium vivax. Journal of Infectious Disease 177 (1998) 1132-1135
13. Calder J.A., Reddy G.R., Chieves L., Courtney C.H., Littell R., Livengood J.R., Norval R.A., Smith C., and Dame J.B. Monitoring Babesia bovis infections in cattle by using PCR-based tests. Journal of Clinical Microbiology 34 (1996) 2748-2755
14. Conrad P., Thomford J., Yamane I., Whiting J., Bosma L., Uno T., Holshuh H.J., and Shelly S. Hemolytic anemia caused by Babesia gibsoni infection in dogs. Journal of the American Veterinary Medical Association 199 (1991) 601-605
15. Conrad P.A., Thomford J.W., Marsh A., Telford III S.R., Anderson J.F., Spielman A., Sabin E.A., Yamane I., and Persing D.H. Ribosomal DNA probe for differentiation of Babesia microti and B. gibsoni isolates. Journal of Clinical Microbiology 30 (1992) 1210-1215
16. Dao A.H., and Eberhard M.L. Pathology of acute fatal babesiosis in hamsters experimentally infected with the WA-1 strain of Babesia. Laboratory Investigation 74 (1996) 853-859
17. Farwell G.E., LeGrand E.K., and Cobb C.C. Clinical observations on Babesia gibsoni and Babesia canis infections in dogs. Journal of the American Veterinary Medical Association 180 (1982) 507-511
18. Fowler J.L., Ruff M.D., Fernau R.C., and Furusho Y. Babesia gibsoni: chemotherapy in dogs. American Journal of Veterinary Research 33 (1972) 1109-1114
19. Fukumoto S., Xuan X., Shigeno S., Kimbita E., Igarashi I., Nagasawa H., Fujisaki K., and Mikami T. Development of a polymerase chain reaction method for diagnosing Babesia gibsoni infection in dogs. Journal of Veterinary Medical Science 63 (2001) 977-981
20. Irizarry-Rovira A.R., Stephens J., Christian J., Kjemtrup A., DeNicola D.B., Widmer W.R., and Conrad P.A. Babesia gibsoni infection in a dog from Indiana. Veterinary Clinical Pathology 30 (2001) 180-188
21. Jarra W., and Snounou G. Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses. Infection and Immunity 66 (1998) 3783-3787
22. Jefferies R., Ryan U.M., and Irwin P.J. Development of a nested PCR-RFLP for the detection and differentiation of the canine piroplasm species and its use with filter paper-based technologies. Veterinary Parasitology 14 (2007) 20-27
23. Krause P.J., Telford III S., Spielman A., Ryan R., Magera J., Rajan T.V., Christianson D., Alberghini T.V., Bow L., and Persing D. Comparison of PCR with blood smear and inoculation of small animals for diagnosis of Babesia microti parasitemia. Journal of Clinical Microbiology 34 (1996) 2791-2794
24. Krause P.J., Lepore T., Sikand V.K., Gadbaw Jr. J., Burk G., Telford III S.R., Brassard P., Pearl D., Azlanzadeh J., Christianson D., McGrath D., and Spielman A. Atovaquone and azithromycin for the treatment of babesiosis. The New England Journal Medicine 343 (2000) 1454-1458
25. Lobetti R.G. Canine Babesiosis. The Compendium 20 (1998) 418-430
26. Looareesuwan S., Viravan C., Webster H.K., Kyle D.E., Hutchinson D.B., and Canfield C.J. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. American Journal of Tropical Medicine and Hygiene 54 (1996) 62-66
27. Macintire D.K., Boudreaux M.K., West G.D., Bourne C., Wright J.C., and Conrad P.A. Babesia gibsoni infection among dogs in the southeastern United States. Journal of the American Veterinary Medical Association 220 (2002) 325-329
28. Matsuu A., Koshida Y., Kawahara M., Inoue K., Ikadai H., Hikasa Y., Okano S., and Higuchi S. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro. Veterinary Parasitology 124 (2004) 9-18
29. Matsuu A., Miyamoto K., Ikadai H., Okano S., and Higuchi S. Cloning of the Babesia gibsoni cytochrome b gene and isolation of three single nucleotide polymorphisms from parasites present after atovaquone treatment. American Journal of Tropical Medicine and Hygiene 74 (2006) 593-597
30. Meinkoth J.H., Kocan A.A., Loud S.D., and Lorenz M.D. Clinical and hematologic effects of experimental infection of dogs with recently identified Babesia gibsoni-like isolates from Oklahoma. Journal of the American Veterinary Medical Association 220 (2002) 185-189
31. Miyama T., Sakata Y., Shimada Y., Ogino S., Watanabe M., Itamoto K., Okuda M., Verdida R.A., Xuan X., Nagasawa H., and Inokuma H. Epidemiological survey of Babesia gibsoni infection in dogs in eastern Japan. Journal of Veterinary Medical Science 67 (2005) 467-471
32. Muhlnickel C.J., Jefferies R., Morgan-Ryan U.M., and Irwin P.J. Babesia gibsoni infection in three dogs in Victoria. Australian Veterinary Journal 80 (2002) 606-610
33. Naidoo V., Zweygarth E., Eloff J.N., and Swan G.E. Identification of anti-babesial activity for four ethnoveterinary plants in vitro. Veterinary Parasitology 130 (2005) 9-13
34. O'Connor R.M., Long J.A., and Allred D.R. Cytoadherence of Babesia bovis-infected erythrocytes to bovine brain capillary endothelial cells provides an in vitro model for sequestration. Infection and Immunity 67 (1999) 3921-3928
35. O'Connor R.M., and Allred D.R. Selection of Babesia bovis-infected erythrocytes for adhesion to endothelial cells coselects for altered variant erythrocyte surface antigen isoforms. Journal of Immunology 164 (2000) 2037-2045
36. Ruff M.D., Fowler J.L., Fernau R.C., and Matsuda K. Action of certain antiprotozoal compounds against Babesia gibsoni in dogs. American Journal of Veterinary Research 34 (1973) 641-645
37. Schetters T.P., Kleuskens J., Scholtes N., and Gorenflot A. Parasite localization and dissemination in the Babesia-infected host. Annals of Tropical Medicine and Parasitology 92 (1998) 513-519
38. Subeki, Matsuura H., Takahashi K., Yamasaki M., Yamato O., Maede Y., Katakura K., Suzuki M., Trimurningsih, Chairul, and Yoshihara T. Antibabesial activity of protoberberine alkaloids and 20-hydroxyecdysone from Arcangelisia flava against Babesia gibsoni in culture. Journal of Veterinary Medical Science 67 (2005) 223-227
39. Taylor W.R., Richie T.L., Fryauff D.J., Picarima H., Ohrt C., Tang D., Braitman D., Murphy G.S., Widjaja H., Tjitra E., Ganjar A., Jones T.R., Basri H., and Berman J. Malaria prophylaxis using azithromycin: a double blind, placebo-controlled trial in Irian Jaya, Indonesia. Clinical Infectious Diseases 28 (1999) 74-81
40. Vial H.J., and Gorenflot A. Chemotherapy against babesiosis. Veterinary Parasitology 138 (2006) 147-160
41. Wilkerson M.J., Shuman W., Swist S., Harkin K., Meinkoth J., and Kocan A.A. Platelet size, platelet surface-associated IgG, and reticulated platelets in dogs with immune-mediated thrombocytopenia. Veterinary Clinical Pathology 30 (2001) 141-149
42. Wittner M., Lederman J., Tanowitz H.B., Rosenbaum G.S., and Weiss L.M. Atovaquone in the treatment of Babesia microti infections in hamsters. American Journal of Tropical Medicine and Hygiene 55 (1996) 219-222
43. Wozniak E.J., Barr B.C., Thomford J.W., Yamane I., McDonough S.P., Moore P.F., Naydan D., Robinson T.W., and Conrad P.A. Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis familiaris). Journal of Parasitology 83 (1997) 692-699
44. Wulansari R., Wijaya A., Ano H., Horii Y., Nasu T., Yamane S., and Makimura S. Clindamycin in the treatment of Babesia gibsoni infections in dogs. Journal of the American Veterinary Medical Association 39 (2003) 558-562
45. Yamane I., Thomford J.W., Gardner I.A., Dubey J.P., Levy M., and Conrad P.A. Evaluation of the indirect fluorescent antibody test for diagnosis of Babesia gibsoni infections in dogs. American Journal of Veterinary Research 54 (1993) 1579-1584